The product is getting near the end of phase 3 trials and the lotion is applied under your arms, gee, wonder if it doubles as a deodorant? 
It is expected to be submitted to the FDA later this year. The product is to replace testosterone in men who’s bodies do not produce enough.
Orion Corporation in Finland will the manufacturing site for the product. BD
Acrux - Developing advanced pharmaceutical products globally
Acrux reports 50% enrolment completed in Testosterone MD-Lotion Phase 3 trial
0 comments :
Post a Comment